Received: 25 February 2021
Accepted: 25 March 2021
First Online: 17 April 2021
: All participating centers obtained Ethics Committee approval from the Radboud University Medical Center Corporate Staff Quality and Safety Committee on Human Research, Arnhem-Nijmegen, Netherlands (Dossier Number: 2014–1226) prior to commencing enrolment. Written informed consent was provided by all study subjects prior to their inclusion into the study.
: Not applicable; no individual patient data are presented in this manuscript.
: Four authors received research support from DePuy Synthes as clinical study investigators in this study, two authors are DePuy Synthes employees, and one or more authors own Johnson & Johnson stock or stock options.